Table of Contents Author Guidelines Submit a Manuscript
International Journal of Endocrinology
Volume 2014, Article ID 674069, 9 pages
http://dx.doi.org/10.1155/2014/674069
Research Article

Effect of GAS6 and AXL Gene Polymorphisms on Adiposity, Systemic Inflammation, and Insulin Resistance in Adolescents

1Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University, Taipei City 110, Taiwan
2Division of Endocrinology and Metabolism, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei City 114, Taiwan
3Department of Physiology and Biophysics, National Defense Medical Center, Taipei City 114, Taiwan
4School of Public Health Department, National Defense Medical Center, Taipei City 114, Taiwan
5Los Angeles Biomedical Research Institute, Harbor-UCLA Medical Center, Torrance, CA 90509, USA
6Department of Oral Diagnosis and Pathology, School of Dentistry, Tri-Service General Hospital, National Defense Medical Center, Taipei City 114, Taiwan
7Division of Endocrinology and Metabolism, Wan Fang Hospital, Taipei Medical University, Taipei City 116, Taiwan

Received 18 October 2013; Revised 21 December 2013; Accepted 7 January 2014; Published 18 February 2014

Academic Editor: Yi-Hao Yu

Copyright © 2014 Fone-Ching Hsiao et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. A. Swinburn, G. Sacks, K. D. Hall et al., “The global obesity pandemic: shaped by global drivers and local environments,” The Lancet, vol. 378, no. 9793, pp. 804–814, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. J. Hebebrand, C. Sommerlad, F. Geller, T. Görg, and A. Hinney, “The genetics of obesity: practical implications,” International Journal of Obesity, vol. 25, supplement 1, pp. S10–S18, 2001. View at Publisher · View at Google Scholar · View at Scopus
  3. I. S. Farooqi and S. O'Rahilly, “New advances in the genetics of early onset obesity,” International Journal of Obesity, vol. 29, no. 10, pp. 1149–1152, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. G. Manfioletti, C. Brancolini, G. Avanzi, and C. Schneider, “The protein encoded by a growth arrest-specific gene (GAS6) is a new member of the vitamin K-dependent proteins related to protein S, a negative coregulator in the blood coagulation cascade,” Molecular and Cellular Biology, vol. 13, no. 8, pp. 4976–4985, 1993. View at Google Scholar · View at Scopus
  5. F. C. Hsiao, Y. F. Lin, P. S. Hsieh et al., “Circulating growth arrest-specific 6 protein is associated with adiposity, systemic inflammation, and insulin resistance among overweight and obese adolescents,” The Journal of Clinical Endocrinology & Metabolism, vol. 98, no. 2, pp. E267–E274, 2013. View at Publisher · View at Google Scholar
  6. C. Schneider, R. M. King, and L. Philipson, “Genes specifically expressed at growth arrest of mammalian cells,” Cell, vol. 54, no. 6, pp. 787–793, 1988. View at Google Scholar · View at Scopus
  7. M. Tjwa, L. Bellido-Martin, Y. Lin et al., “Gas6 promotes inflammation by enhancing interactions between endothelial cells, platelets, and leukocytes,” Blood, vol. 111, no. 8, pp. 4096–4105, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. E. Lutgens, M. Tjwa, P. G. De Frutos et al., “Genetic loss of GAS6 induces plaque stability in experimental atherosclerosis,” Journal of Pathology, vol. 216, no. 1, pp. 55–63, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. E. Maquoi, G. Vörös, P. Carmeliet, D. Collen, and H. R. Lijnen, “Role of GAS-6 in adipogenesis and nutritionally induced adipose tissue development in mice,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 25, no. 5, pp. 1002–1007, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. P. J. Godowski, M. R. Mark, J. Chen, M. D. Sadick, H. Raab, and R. G. Hammonds, “Reevaluation of the roles of protein S and GAS6 as ligands for the receptor tyrosine kinase Rse/Tyro 3,” Cell, vol. 82, no. 3, pp. 355–358, 1995. View at Google Scholar · View at Scopus
  11. S. Goruppi, E. Ruaro, and C. Schneider, “GAS6, the ligand of Axl tyrosine kinase receptor, has mitogenic and survival activities for serum starved NIH3T3 fibroblasts,” Oncogene, vol. 12, no. 3, pp. 471–480, 1996. View at Google Scholar · View at Scopus
  12. E. C. Shugart, A. S. Levenson, C. M. Constance, and R. M. Umek, “Differential expression of GAS and GADD genes at distinct growth arrest points during adipocyte development,” Cell Growth and Differentiation, vol. 6, no. 12, pp. 1541–1547, 1995. View at Google Scholar · View at Scopus
  13. H. R. Lijnen, V. Christiaens, and L. Scroyen, “Growth arrest-specific protein 6 receptor antagonism impairs adipocyte differentiation and adipose tissue development in mice,” Journal of Pharmacology and Experimental Therapeutics, vol. 337, no. 2, pp. 457–464, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. K. A. Augustine, R. M. Rossi, G. Van et al., “Noninsulin-dependent diabetes mellitus occurs in mice ectopically expressing the human Axl tyrosine kinase receptor,” Journal of Cellular Physiology, vol. 181, no. 3, pp. 433–447, 1999. View at Google Scholar
  15. M. Škopková, A. Penesová, H. Sell et al., “Protein array reveals differentially expressed proteins in subcutaneous adipose tissue in obesity,” Obesity, vol. 15, no. 10, pp. 2396–2406, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. V. A. Korshunov, A. M. Mohan, M. A. Georger, and B. C. Berk, “Axl, a receptor tyrosine kinase, mediates flow-induced vascular remodeling,” Circulation Research, vol. 98, no. 11, pp. 1446–1452, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. F. Lafdil, M.-N. Chobert, V. Deveaux et al., “Growth arrest-specific protein 6 deficiency impairs liver tissue repair after acute toxic hepatitis in mice,” Journal of Hepatology, vol. 51, no. 1, pp. 55–66, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. S. Schenk, M. Saberi, and J. M. Olefsky, “Insulin sensitivity: modulation by nutrients and inflammation,” Journal of Clinical Investigation, vol. 118, no. 9, pp. 2992–3002, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. C. Herder, S. Schneitler, W. Rathmann et al., “Low-grade inflammation, obesity, and insulin resistance in adolescents,” Journal of Clinical Endocrinology and Metabolism, vol. 92, no. 12, pp. 4569–4574, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. C. N. Lumeng and A. R. Saltiel, “Inflammatory links between obesity and metabolic disease,” Journal of Clinical Investigation, vol. 121, no. 6, pp. 2111–2117, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. C. S. Tam, K. Clément, L. A. Baur, and J. Tordjman, “Obesity and low-grade inflammation: a paediatric perspective,” Obesity Reviews, vol. 11, no. 2, pp. 118–126, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. X. Muñoz, V. Obach, B. Hurtado, P. G. de Frutos, Á. Chamorro, and N. Sala, “Association of specific haplotypes of GAS6 gene with stroke,” Thrombosis and Haemostasis, vol. 98, no. 2, pp. 406–412, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. L. Jiang, C. Y. Liu, Q. F. Yang, P. Wang, and W. Zhang, “Plasma level of growth arrest-specific 6 (GAS6) protein and genetic variations in the GAS6 gene in patients with acute coronary syndrome,” American Journal of Clinical Pathology, vol. 131, no. 5, pp. 738–743, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. C.-H. Lee, N.-F. Chu, Y.-S. Shieh, and Y.-J. Hung, “The growth arrest-specific 6 (GAS6) gene polymorphism c.834+7G>A is associated with type 2 diabetes,” Diabetes Research and Clinical Practice, vol. 95, no. 2, pp. 201–206, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. F.-H. Lin, N.-F. Chu, C.-H. Lee, Y.-J. Hung, and D.-M. Wu, “Combined effect of C-reactive protein gene SNP +2147 A/G and interleukin-6 receptor gene SNP rs2229238 C/T on anthropometric characteristics among school children in Taiwan,” International Journal of Obesity, vol. 35, no. 4, pp. 587–594, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. Y. Huang, “Body mass index reference for taiwanese children and adolescents,” Journal of Medical Sciences, vol. 22, no. 5, pp. 221–226, 2002. View at Google Scholar
  27. R. Muniyappa, S. Lee, H. Chen, and M. J. Quon, “Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage,” American Journal of Physiology—Endocrinology and Metabolism, vol. 294, no. 1, pp. E15–E26, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. Y.-J. Hung, C.-H. Lee, N.-F. Chu, and Y.-S. Shieh, “Plasma protein growth arrest-specific 6 levels are associated with altered glucose tolerance, inflammation, and endothelial dysfunction,” Diabetes Care, vol. 33, no. 8, pp. 1840–1844, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. F. Alciato, P. P. Sainaghi, L. Castello, L. Bergamasco, S. Carnieletto, and G. C. Avanzi, “Development and validation of an ELISA method for detection of Growth Arrest Specific 6 (GAS6) protein in human plasma,” Journal of Immunoassay and Immunochemistry, vol. 29, no. 2, pp. 167–180, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. B. Hurtado, N. Abasolo, X. Muñoz et al., “Association study between polymorphims in GAS6-TAM genes and carotid atherosclerosis,” Thrombosis and Haemostasis, vol. 104, no. 3, pp. 592–598, 2010. View at Publisher · View at Google Scholar · View at Scopus
  31. C. Ekman, A. Linder, P. Åkesson, and B. Dahlbäck, “Plasma concentrations of GAS6 (growth arrest specific protein 6) and its soluble tyrosine kinase receptor sAxl in sepsis and systemic inflammatory response syndromes,” Critical Care, vol. 14, no. 4, article R158, 2010. View at Publisher · View at Google Scholar · View at Scopus
  32. C. Ekman, A. Jonsen, G. Sturfelt, A. A. Bengtsson, and B. Dahlback:, “Plasma concentrations of GAS6 and sAxl correlate with disease activity in systemic lupus erythematosus,” Rheumatology, vol. 50, no. 6, pp. 1064–1069, 2011. View at Google Scholar
  33. A. Caraux, Q. Lu, N. Fernandez et al., “Natural killer cell differentiation driven by Tyro3 receptor tyrosine kinases,” Nature Immunology, vol. 7, no. 7, pp. 747–754, 2006. View at Publisher · View at Google Scholar · View at Scopus
  34. C. V. Rothlin, S. Ghosh, E. I. Zuniga, M. B. A. Oldstone, and G. Lemke, “TAM receptors are pleiotropic inhibitors of the innate immune response,” Cell, vol. 131, no. 6, pp. 1124–1136, 2007. View at Publisher · View at Google Scholar · View at Scopus
  35. T. N. Stitt, G. Conn, M. Gore et al., “The anticoagulation factor protein S and its relative, GAS6, are ligands for the tyro 3/Axl family of receptor tyrosine kinases,” Cell, vol. 80, no. 4, pp. 661–670, 1995. View at Google Scholar · View at Scopus
  36. K. Nagata, K. Ohashi, T. Nakano et al., “Identification of the product of growth arrest-specific gene 6 as a common ligand for Axl, Sky, and Mer receptor tyrosine kinases,” Journal of Biological Chemistry, vol. 271, no. 47, pp. 30022–30027, 1996. View at Publisher · View at Google Scholar · View at Scopus
  37. I. Scroyen, L. Frederix, and H. R. Lijnen, “Axl deficiency does not affect adipogenesis or adipose tissue development,” Obesity, vol. 20, no. 6, pp. 1168–1173, 2012. View at Publisher · View at Google Scholar · View at Scopus
  38. R. Mo, Y. T. Zhu, Z. Zhang, S. M. Rao, and Y.-J. Zhu, “GAS6 is an estrogen-inducible gene in mammary epithelial cells,” Biochemical and Biophysical Research Communications, vol. 353, no. 1, pp. 189–194, 2007. View at Publisher · View at Google Scholar · View at Scopus
  39. B.-K. Son, M. Akishita, K. Iijima et al., “Androgen receptor-dependent transactivation of growth arrest-specific gene 6 mediates inhibitory effects of testosterone on vascular calcification,” Journal of Biological Chemistry, vol. 285, no. 10, pp. 7537–7544, 2010. View at Publisher · View at Google Scholar · View at Scopus
  40. N. Abate, S. M. Haffner, A. Garg, R. M. Peshock, and S. M. Grundy, “Sex steroid hormones, upper body obesity, and insulin resistance,” Journal of Clinical Endocrinology and Metabolism, vol. 87, no. 10, pp. 4522–4527, 2002. View at Publisher · View at Google Scholar · View at Scopus
  41. S. M. Haffner, “Sex hormones, obesity, fat distribution, type 2 diabetes and insulin resistance: epidemiological and clinical correlation,” International Journal of Obesity, vol. 24, supplement 2, pp. S56–S58, 2000. View at Publisher · View at Google Scholar · View at Scopus